The Claim
Pharmacological inhibition or siRNA-mediated knockdown of TAS1R3 in human skeletal muscle cells reduces insulin-stimulated glucose uptake by approximately 50%, indicating that TAS1R3 is necessary for normal glucose disposal in human myotubes.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Blocking the TAS1R3 protein in human muscle cells reduces the amount of glucose those cells take up in response to insulin by about half.
See the scientific wording
Pharmacological inhibition or siRNA-mediated knockdown of TAS1R3 in human skeletal muscle cells reduces insulin-stimulated glucose uptake by approximately 50%, indicating that TAS1R3 is necessary for normal glucose disposal in human myotubes.
When sugar is present, a protein called TAS1R3 in muscle cells activates a chain reaction that rearranges the cell's internal skeleton, allowing sugar transporters to move to the cell surface so sugar can enter the cell. Without TAS1R3, this chain reaction stops, sugar transporters stay inside, and sugar cannot enter the muscle cell even when insulin is present.
What the research says
1 studyStudy: TAS1R3 Regulates GTPase Signaling in Human Skeletal Muscle Cells for Glucose Uptake
When scientists turned off a protein called TAS1R3 in human muscle cells in the lab, those cells took up about half as much sugar from the blood when insulin was present — meaning this protein is needed for insulin to work properly in muscle.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.